BET1
BET1 homolog
Also known as: BET1_HUMAN, hbet1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15155
- Gene
- BET1
- Ensembl
- ENSG00000105829
- Chromosome
- 7
- Canonical length
- 118 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a golgi-associated membrane protein that participates in vesicular transport from the endoplasmic reticulum (ER) to the Golgi complex. The encoded protein functions as a soluble N-ethylaleimide-sensitive factor attachment protein receptor and may be involved in the docking of ER-derived vesicles with the cis-Golgi membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
118 residues, UniProt reviewed canonical sequence.
>O15155|BET1
1 MRRAGLGEGV PPGNYGNYGY ANSGYSACEE ENERLTESLR SKVTAIKSLS IEIGHEVKTQ
61 NKLLAEMDSQ FDSTTGFLGK TMGKLKILSR GSQTKLLCYM MLFSLFVFFI IYWIIKLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BET1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- placenta: 34 nTPM
- epididymis: 32 nTPM
- liver: 30 nTPM
- adrenal gland: 27 nTPM
- ovary: 26 nTPM
- salivary gland: 25 nTPM
Single-cell type
- extravillous trophoblasts: 261 nCPM
- syncytiotrophoblasts: 164 nCPM
- epididymal principal cells: 153 nCPM
- lactotrophs: 152 nCPM
- migrating cytotrophoblasts: 115 nCPM
- breast lactating cells: 99 nCPM
Immune cell
- basophil: 63 nTPM
- memory B-cell: 41 nTPM
- plasmacytoid DC: 40 nTPM
- naive B-cell: 38 nTPM
- naive CD4 T-cell: 27 nTPM
- MAIT T-cell: 26 nTPM
Brain region
- choroid plexus: 19 nTPM
- white matter: 16 nTPM
- hypothalamus: 15 nTPM
- medulla oblongata: 12 nTPM
- midbrain: 12 nTPM
- spinal cord: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BET1.
Disease | AllUniProt
Conditions BET1 is implicated in, by any mechanism.
- Muscular dystrophy, congenital, with rapid progression (MDRP) MIM:254100
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 19 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Muscular dystrophy, congenital, with rapid progression
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum to Golgi vesicle-mediated transport
- protein transport
- vesicle fusion with Golgi apparatus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BET1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BET1 as an antibody target. Whether an autoantibody or antibody against BET1 could matter depends on whether native BET1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BET1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BET1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...